LUND, SWEDEN, June 20, 2022 - Oncorena AB, which is developing a new and potentially groundbreaking treatment for patients with advanced kidney cancer, announces that the Board of Directors  of Oncorena AB has appointed Professor Börje Haraldsson as CEO of the...

read more